Compare Home Depot Inc (HD) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs Medtronic PLC — how do they compare? Home Depot Inc trades at $333.56 (market cap $332.08B), while Medtronic PLC trades at $83.21 (market cap $106.61B). The key difference: Home Depot Inc is far larger — about 3.1× Medtronic PLC's market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| HD | MDT | |
|---|---|---|
Market Cap | $332.08B | $106.61B |
Sector | Consumer Cyclical | Health |
52-Week High | $423.42 | $105.35 |
52-Week Low | $297.51 | $73.75 |
Enterprise Value | $393.64B | $125.36B |
Dividend Yield | 2.8% | 3.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $338.87, down 2.63% amid bearish technical signals and mixed fundamental performance. The stock shows strong profitability with 8.41% net margin and 128.38% ROE, but faces margin compression with profit margins declining from 10.87% in 2022 to 9.28% in 2025. Recent earnings show mixed results with Q3 2025 missing expectations while Q4 2025 and Q1 2026 beat estimates. Technical analysis indicates bearish momentum with key support at $321 and resistance at $343.
Despite near-term headwinds, HD maintains strong analyst support with 59% buy ratings and $370.59 consensus target, representing 9.4% upside. The company's robust cash flow generation and Pro business growth provide long-term stability, though rising mortgage rates and housing market sensitivity pose significant risks to near-term performance.
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
